Repurposing of High-Dose Erythropoietin as a Potential Drug Attenuates Sepsis in Preconditioning Renal Injury

Due to (i) the uremia-enhanced sepsis severity, (ii) the high prevalence of sepsis with pre-existing renal injury and (iii) the non-erythropoiesis immunomodulation of erythropoietin (EPO), EPO was tested in sepsis with pre-existing renal injury models with the retrospective exploration in patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Chancharoenthana, Wiwat, Udompronpitak, Kanyarat, Manochantr, Yolradee, Kantagowit, Piyawat, Kaewkanha, Ponthakorn, Issara-Amphorn, Jiraporn, Leelahavanichkul, Asada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617638/
https://www.ncbi.nlm.nih.gov/pubmed/34831360
http://dx.doi.org/10.3390/cells10113133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617638/
https://www.ncbi.nlm.nih.gov/pubmed/34831360
http://dx.doi.org/10.3390/cells10113133

Ejemplares similares